ClinicalTrials.gg
Not yet recruitingNCT05829941Updated Apr 28, 2023

Technology Assisted Treatment for Binge Eating Behavior

An interventional study of Smartwatch app to deliver binge-eating CBT strategies and Reminder control condition in Binge-Eating Disorder, sponsored by HabitAware Inc.. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-28.

Sponsored by HabitAware Inc. · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Binge-eating behavior is a central feature of eating disorders (e.g., binge-eating disorder, bulimia nervosa, anorexia nervosa-binge-eating/purging subtype) and is associated with higher rates of psychopathology, psychosocial impairment, medical comorbidity, and more severe obesity, all of which pose significant public health problems. Passive detection of binge eating episodes combined with a context-based reminder intervention could assist a patient in resuming healthy eating patterns. This study will test a smartwatch app that identifies binge eating behavior and provides CBT strategies to the patient after the episode.

02

Conditions studied

  • Binge-Eating Disorder

Browse trials for

03

In context

Binge-Eating Disorder

233 studies on the registry are indexed under Binge-Eating Disorder; 51 are open to participants now.

This study's planned enrollment of 30 is below the median of 77 across 190 interventional studies indexed under Binge-Eating Disorder.

Browse Binge-Eating Disorder studies →

Lead sponsor

HabitAware Inc. is the lead sponsor of 4 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adults ≥18 years of age
  2. EDE diagnosis of bulimia nervosa or binge eating disorder, with binge-eating episodes occurring at least 2x/week

Exclusion criteria

Exclusion Criteria:

  1. Pregnancy or lactation
  2. Acute medical or psychiatric risk
  3. Psychosis or bipolar disorder (lifetime history)
  4. Current substance use disorder within the past six months
  5. less than 18.5 kg/m2
  6. Acute suicidality requiring hospitalization
  7. Food allergies
  8. Receiving current psychotherapy
  9. On psychotropic medications that have not been on a stable dose for at least six weeks
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    HabitAware condition

    This group will receive the device which messages the participant after a passively detected binge-eating episode with CBT strategies.

    Behavioral: Smartwatch app to deliver binge-eating CBT strategies

  • Placebo comparator
    Reminder Condition

    This group will receive a device that vibrates randomly throughout the day as a reminder not to binge eat.

    Behavioral: Reminder control condition

Interventions

  • BehavioralSmartwatch app to deliver binge-eating CBT strategies

    Participants will receive a smartwatch with a pre-loaded app that will alert the participant to relevant binge-eating strategies based on their previous detected behavior.

  • BehavioralReminder control condition

    Participants will receive a smartwatch that vibrates randomly, and will be instructed the vibration is a cue not to binge eat.

06

What researchers measure

Primary outcomes

  1. Percentage of patients in the HabitAware condition that report the treatment is acceptable.

    Measured via post-treatment survey

    Time frame: 8 weeks

Secondary outcomes

  1. Percentage of patients report that the binge episode detection is accurate

    Measured via post-treatment survey

    Time frame: 8 weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2024; primary completion for Jun 2025, 6 months later.

Of 87 interventional studies with no phase under Binge-Eating Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 53. This study's planned 6 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 13, 2023
First posted
Apr 26, 2023
StartEst.
Dec 2024
Primary completionEst.
Jun 2025
CompletionEst.
Aug 2025
Last update
Apr 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05829941
Lead sponsor
HabitAware Inc.
Responsible party
Sponsor
First posted
Apr 26, 2023
Start date
Dec 2024 (estimated)
Primary completion
Jun 2025 (estimated)
Completion
Aug 2025 (estimated)
Last update
Apr 28, 2023

Study contacts

Sameer Kumar, BS
Contact
sameer@habitaware.com
2489904720

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion